Corcept Therapeutics Inc. | Key People and Executives
Joseph K. Belanoff
President, Chief Executive Officer, Director & MD
Renee D. Gala
Independent Director
Daniel N. Swisher
Independent Director
Daniel Mark Bradbury
Independent Director
George Leonard Baker
Independent Director
David L. Mahoney
Independent Director
Joseph K. Belanoff
President, Chief Executive Officer, Director & MD
Gary Charles Robb
Secretary & Chief Financial Officer
Hazel Hunt
Senior Vice President-Research
Robert S. Fishman
Chief Medical Officer
Sean Maduck
Senior Vice President-Commercial
Thaddeus S. Block
Vice President-Clinical Development
J. D. Lyon
Vice President-Corporate Controller
Susan P. Rinne
Vice President-Corporate Regulatory Affairs
Renee D. Gala
Independent Director
Daniel N. Swisher
Independent Director
Daniel Mark Bradbury
Independent Director
George Leonard Baker
Independent Director
David L. Mahoney
Independent Director
Address |
149 Commonwealth Drive Menlo Park California 94025 United States
|
Employees
|
- |
Website |
http://www.corcept.com |
Updated |
07/08/2019 |
Corcept Therapeutics, Inc. engages in the development of drugs for the treatment of severe psychiatric, neurological, and metabolic disorders. It focuses on the development of drugs for disorders that are associated with a steroid hormone called cortisol. Its products include korlym and korlym support. |